Previous research of Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL) using a CDK6 degrader showed the rapid and preferential degradation of CDK6 over CDK4 [20]. This evidence concerns the gene CDK6 and acute lymphoblastic leukemia.